Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

BioNTech SE

NASDAQ: BNTX · Life Sciences · 8 alerts · CIK 1776985

Share price
$85.26Close, Nov 16
Market cap
$21.4B
Shares outstanding
251.2MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All BioNTech SE filings on SEC EDGAR ↗

4:47 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $5.95M of Stock

Ugur Sahin, CEO, sold 63,209 shares of BioNTech SE at $92.31 to $95.37 a share (average $94.07) in 2 transactions, worth $5.95M in total between Oct 8, 2026 and Oct 9, 2026. Shares held after the trade: 0 (-100.0%).

Value
$5.95M
Shares
63,209
Average price
$94.07
Role
CEO
Holding change
-100.0%
Trade date
Oct 8, 2026 to Oct 9, 2026
5:14 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $2.3M of Stock

Ugur Sahin, CEO, sold 24,000 shares of BioNTech SE at $95.86 a share, worth $2.3M in total on Oct 7, 2026. Shares held after the trade: 63,209 (-27.5%).

Value
$2.3M
Shares
24,000
Price
$95.86
Role
CEO
Holding change
-27.5%
Trade date
Oct 7, 2026
4:59 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $9.03M of Stock

Ugur Sahin, CEO, sold 93,000 shares of BioNTech SE at $96.81 to $97.23 a share (average $97.14) in 2 transactions, worth $9.03M in total between Oct 5, 2026 and Oct 6, 2026. Shares held after the trade: 87,209 (-19.4%).

Value
$9.03M
Shares
93,000
Average price
$97.14
Role
CEO
Holding change
-19.4%
Trade date
Oct 5, 2026 to Oct 6, 2026
4:28 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $3.3M of Stock

Ugur Sahin, CEO, sold 34,000 shares of BioNTech SE at $96.72 to $97.46 a share (average $97.09) in 2 transactions, worth $3.3M in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 180,209 (-8.6%).

Value
$3.3M
Shares
34,000
Average price
$97.09
Role
CEO
Holding change
-8.6%
Trade date
Oct 1, 2026 to Oct 2, 2026
4:30 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $6.48M of Stock

Ugur Sahin, CEO, sold 66,000 shares of BioNTech SE at $98.12 to $98.26 a share (average $98.19) in 2 transactions, worth $6.48M in total between Sep 29, 2026 and Sep 30, 2026. Shares held after the trade: 214,209 (-13.0%).

Value
$6.48M
Shares
66,000
Average price
$98.19
Role
CEO
Holding change
-13.0%
Trade date
Sep 29, 2026 to Sep 30, 2026
4:42 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $6.24M of Stock

Ugur Sahin, CEO, sold 64,000 shares of BioNTech SE at $96.22 to $98.60 a share (average $97.49) in 2 transactions, worth $6.24M in total between Sep 17, 2026 and Sep 18, 2026. Shares held after the trade: 489,209 (-5.8%).

Value
$6.24M
Shares
64,000
Average price
$97.49
Role
CEO
Holding change
-5.8%
Trade date
Sep 17, 2026 to Sep 18, 2026
4:47 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $4.72M of Stock

Ugur Sahin, CEO, sold 49,000 shares of BioNTech SE at $96.09 to $96.49 a share (average $96.37) in 2 transactions, worth $4.72M in total between Sep 15, 2026 and Sep 16, 2026. Shares held after the trade: 553,209 (-2.6%).

Value
$4.72M
Shares
49,000
Average price
$96.37
Role
CEO
Holding change
-2.6%
Trade date
Sep 15, 2026 to Sep 16, 2026
4:52 PM ET Form 4
Insider Selling

BioNTech CEO Ugur Sahin Sells $8.44M of Stock

Ugur Sahin, CEO, sold 86,000 shares of BioNTech SE at $96.93 to $99.45 a share (average $98.13) in 2 transactions, worth $8.44M in total between Sep 11, 2026 and Sep 14, 2026. Shares held after the trade: 602,209 (-6.4%).

Value
$8.44M
Shares
86,000
Average price
$98.13
Role
CEO
Holding change
-6.4%
Trade date
Sep 11, 2026 to Sep 14, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.